Vascular Medicine
A section of Journal of Clinical Medicine (ISSN 2077-0383).
Section Information
The Vascular Medicine Section of the Journal of Clinical Medicine is aimed primarily at physicians and scientists dealing with patients with arterial, venous and lymphatic diseases. This section will include contributions considering the diagnosis, investigation and management of these vascular disorders. We welcome translational and clinical research presenting novel results of the highest quality in any area of vascular biology and medicine, including inflammation, thrombosis and bleeding. Diagnostic, therapeutic and preventative studies are welcome. Reports describing endovascular methods and their critical evaluation are included within the scope of this section, as are articles on the emerging technology associated with this field. Our goal is to facilitate rapid communication and high visibility of vascular medicine research through swift online processing and dissemination.
Subject Areas
- Thrombosis/coagulation
- Vascular physiology
- Aneurysm
- Platelet
- Leukocyte
- Endothelium
- Inflammation
- Peripheral artery disease
- Venous thromboembolism
- Acute pulmonary embolism
- Stents
- Others
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Hypertension in Adults: Current Updates on Diagnosis, Treatment and Management (Deadline: 15 May 2025)
- Recent Developments and Emerging Trends in Aortic Surgery (Deadline: 28 May 2025)
- Systemic Vasculitis: Advancement in Pathogenesis, Clinical Features, Management and Therapeutic Strategies (Deadline: 31 May 2025)
- Revascularization Strategies in Peripheral Artery Disease and Chronic Limb-Threatening Ischemia: Current Standards and Future Perspectives (Deadline: 5 June 2025)
- Clinical Advances in Aortic Disease and Revascularization (Deadline: 30 June 2025)
- Advances in Aortic Surgery (Deadline: 30 June 2025)
- Clinical Advances in Vascular and Endovascular Surgery (Deadline: 30 June 2025)
- Vasculitis in Adults and Children: Symptoms, Diagnosis and Treatment—2nd Edition (Deadline: 25 July 2025)
- Clinical Advances and Challenges in Vascular and Endovascular Medicine (Deadline: 31 July 2025)
- Vascular Surgery: Current Status and Future Perspectives (Deadline: 31 July 2025)
- State of the Art in Invasive Vascular Interventions (Second Edition) (Deadline: 20 August 2025)
- Clinical Updates on Hereditary Hemorrhagic Telangiectasia (HHT) and Other Vascular Diseases (Deadline: 29 August 2025)
- Current Trends in Vascular and Endovascular Surgery (Deadline: 15 September 2025)
- New Insights into Minimally Invasive Vascular Surgery (Deadline: 23 September 2025)
- Clinical Application of Artificial Intelligence in Vascular Surgery (Deadline: 25 September 2025)
- Vascular and Endovascular Surgery: Current Progress and Future Challenges (Deadline: 28 September 2025)
- State of the Art in Management of Aortic Aneurysm in Vascular Surgery (Deadline: 30 September 2025)
- Thrombosis and Haemostasis: Clinical Advances (Deadline: 30 September 2025)
- Advancements in Venous Disease Management: From Conservative to Interventional Treatments (Deadline: 30 September 2025)
- Sequelae of COVID-19: Clinical to Prognostic Follow-Up (Deadline: 30 September 2025)
- Endovascular Surgery: State of the Art and Clinical Perspectives (Deadline: 9 October 2025)
- Hereditary Hemorrhagic Telangiectasia: Recent Advances and Future Challenges—2nd Edition (Deadline: 25 October 2025)
- Pathophysiology of Hypertension and Related Diseases: 2nd Edition (Deadline: 25 October 2025)
- Advancements in Venous Thrombosis Management: From Prevention to Long-Term Care (Deadline: 30 October 2025)
- Clinical Research in Vascular Access Devices (Deadline: 30 November 2025)
- Clinical Perspectives of Vascular and Endovascular Surgeries (Deadline: 20 December 2025)
- Managements of Venous Thromboembolism (Deadline: 29 December 2025)
- Optimizing Outcomes in Deep Vein Thrombosis: A Focus on Interventional Management (Deadline: 31 December 2025)
- The Optimal Hybrid Revascularization Approach for Multilevel Peripheral Arterial Disease (Deadline: 30 January 2026)
